alta-icon logo-altasciences

EN - Main navigation

  • Navigating COVID-19
  • Proactive Drug Development
  • Solutions
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • Contact Us
  • Participate in a study
  • Request for information
Français
  • Home
  • Bioanalytical Services
  • Current: Ligand Binding

Ligand Binding

 

Our ligand binding group offers support for Immunogenicity, PD, PK, BE, and biosimilar studies for both preclinical and clinical stages of drug development.

We have nearly a decade of experience with small and large molecules, such as oligonucleotides, small peptides, chemical elements, proteins, bi-specific antibodies, monoclonal antibodies, and antibody-drug conjugates. Depending on the level of sensitivity, complexity of your drug, or the need to multiplex or have a high-throughput sample analysis for your study, our scientists will propose the most suitable equipment for your needs.

Our ligand binding assay types:

  • Immunogenicity assays:
    • ADA: screening, confirmatory and titration
    • nAb by non-cell based and cell-based assays
  • Quantification methods using various platforms
  • Hybridization ELISA/ECLIA of various types (ligation, dual hybridization)
  • Functional cell-based assays
  • Biomarkers
  • Cell lineage and functional immunophenotyping by flow cytometry
  • PCR analysis (Droplet digital PCR, Quantitative PCR)
  • Cytokine/Chemokine Analysis
  • Electrochemiluminescence (ECL)

Our ligand binding equipment includes:

  • Mesoscale S600 Electrochemiluminescence Sector Imager
  • BioTek Synergy H4 Multimode Plate Reader using Absorbance, Fluorescence, or Luminescence
  • Luminex 200 System
  • Simoa HD-1 Analyzer
  • BioTek EL406 Microplate Washer/Dispenser
  • BD Biosciences FACSCantoTM II Cytometer
  • SpeedVac for tissue extraction
  • Percellys®  Evolution Homogenizer

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Press Kit
    • Resource Center

      • The Altascientist
      • Webinars/Podcasts
      • eBulletins
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Acute Toxicology
      • Dose Range Finding​/​Maximum Tolerated Dose
      • Repeated Dose Toxicity
      • Safety Pharmacology
      • Sub-Chronic/Chronic, Repeated Dose Toxicity
      • Clinical
      • First in Human
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • Driving Simulation
      • Drug-Drug Interaction
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
      • Cannabis
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2021 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Have a question?

I'd be happy to help.

Captcha is required.